INTRODUCTION AND OBJECTIVES: Many urologists are hesitant to offer surgical treatment for urinary incontinence in the genitourinary cancer survivor with significant comorbidities. We used the Charlson Comorbidity Index (CCI) and Frailty Index (FI) to investigate the relationship between preoperative comorbidity and immediate outcomes after artificial urinary sphincter (AUS) implantation. We hypothesized that even high-risk patients do well with this surgery.
INTRODUCTION AND OBJECTIVES: Many urologists are hesitant to offer surgical treatment for urinary incontinence in the genitourinary cancer survivor with significant comorbidities. We used the Charlson Comorbidity Index (CCI) and Frailty Index (FI) to investigate the relationship between preoperative comorbidity and immediate outcomes after artificial urinary sphincter (AUS) implantation. We hypothesized that even high-risk patients do well with this surgery.
METHODS: Using the National Surgical Quality Improvement Program (NSQIP), patients with CPT codes for AUS implantation were identified between 2007 and 2015. The patient's CCI was calculated based on ICD-9 codes. We calculated a FI score for each patient by adding the number of FI conditions the patient had, based on ICD-9 diagnoses. Complications were identified based on definitions in NSQIP and converted to Clavien-Dindo classification grades. Weighted descriptive statistics were calculated. Weighted multivariate logistic regression was used to examine the association between Grade I, Grade III, and overall complication and CCI, controlling for anesthesia type and race. We also used logistic regression to study the association between Grade I, Grade III, and overall complication and FI, controlling for age, anesthesia type, and race.
RESULTS: We reviewed data on 1370 patients. The mean age of patients was 70 AE 9.6 years old. 77% were Caucasian and the mean BMI was 29.6. 96% of patients had general anesthesia. The mean CCI was 4.0 AE 1.4. 47% of patients had only 1 FI condition whereas 25% had 2 or more FI conditions. For each post-operative complication recorded in NSQIP, less than 3% of the patients in this population exhibit any of these complications. Therefore, we only modeled Clavien-Dindo Grade I, III and overall complication. After adjusting for anesthesia and race, there were no association between having each of Grade I (OR [ 1.11; 95% CI [ 0.89, 1.38; 
INTRODUCTION AND OBJECTIVES:
Optimizing sizing of an artificial urinary sphincter (AUS) cuff is of paramount importance for technical success as well as quality of life (QOL) improvement in men with post-prostatectomy incontinence. Correct selection of the size of the artificial urinary sphincter cuff at the time of placement is dependent upon intraoperative measurement of the circumference of the urethra. Currently, there is no consensus on whether it is better to measure the urethra with or without a Foley catheter in place and it is unknown how this affects the chosen cuff size. We hypothesized that urethral circumferential measurement is not altered based on the presence or absence of a Foley catheter.
METHODS: We performed a retrospective review of prospectively collected data for purposes of institutional quality improvement. The prospective data was collected on consecutive first-time placement of a trans-perineal AUS from 2015 until 2018. Only men without a history of radiation and without a history of prior male sling or AUS were included. We performed a series of measurements during the procedure -without a catheter, with a 12Fr catheter and finally with a 16Fr catheter. The measurements were made using sterile umbilical tape cut to fit and a ruler. These were recorded, as was the final cuff size. Comparison was made between each measurement and the final cuff size.
RESULTS: Forty-seven patients were included in the analysis. As depicted in table 1, data was analyzed using a Spearman's coefficient revealing significant correlation between each measurement with less than 0.1 mm mean difference (p <0.0001). The cuff size chosen was between 4 and 5.5 cm with 47% of the cuffs chosen being 4.5 cm. There was no significant difference in the measurements of circumference without a catheter, with a 12 or 16 French catheter in place (p<0.0001) suggesting that final cuff size was not influenced by the presence or absence of a urethral catheter.
CONCLUSIONS: The presence of a urethral catheter does not influence circumferential measurement during AUS implantation. Because of this, we no longer routinely remove the catheter during the measuring portion of the procedure. We feel that minimizing catheter manipulation will potentially translate into decreased complication rates due to decreased length of the procedure and decreased exposure of the implant.
Source of Funding: none

PD37-09 IS AN OVERNIGHT STAY NECESSARY AFTER ARTIFICIAL URINARY SPHINCTER INSERTION?
Benjamin Dropkin*, Nashville, TN; Jeremiah Dallmer, Leah Chisholm, Nashville, TN; Siobahn Hartigan, Sophia Delpe, Douglas Milam, Melissa Kaufman, Nashville, TN INTRODUCTION AND OBJECTIVES: Artificial Urinary Sphincter (AUS) insertion is the most effective treatment for moderate to severe incontinence in men. With over 3500 devices placed annually in the United States, a significant cost burden is associated with inpatient care. We sought to determine whether inpatient management after AUS insertion, our current local standard of care, is necessary with regards to pain control and immediate postoperative complications.
METHODS: In this IRB approved, retrospective review, AUS insertions between June 2013 and September 2017 were identified by CPT code 53445. Medical records were reviewed for patient demographics, medical and surgical history, length of stay, postoperative narcotic use, and immediate postoperative complications.
RESULTS: We identified 163 men who met inclusion criteria. The mean age and BMI were 69.3 þ 9.4 years and 29.6 þ 9.7 kg/m2, respectively. Twenty-three (14 %) patients were using chronic narcotic pain medication preoperatively, 33 (20 %) were on anticoagulation other than ASA-81 mg, and 51 (31 %) had diabetes (mean hemoglobin A1c 7.0 þ 1.5 %). Patient history included radical prostatectomy (RP) alone in 95 (58 %), radiation (XRT) alone in 15 (9 %), and RP and XRT in 40 (25 %). Twenty (12%) patients had a history of TURP or HoLEP, 14 of whom also had a history of RP and/or XRT. Sixteen (10 %) patients had a history of prior AUS.
All patients were discharged on the first postoperative day (POD 1) except for one patient discharged on POD 2. Two (1.2 %) patients experienced postoperative complications prior to discharge. One patient demonstrated altered mental status that resolved with conservative management (Clavien grade I) and the second displayed postoperative tachycardia requiring medical therapy (Clavien grade II). The 154 (94%) patients who required post-PACU narcotic pain medication used a median of 31.1 (IQR 15-45) morphine milligram equivalents (mme). The 82 (50%) patients who required post-PACU IV narcotic pain medication used a median of 4 (IQR 2-6) mme.
CONCLUSIONS: The vast majority of patients underwent uncomplicated AUS insertions with minimal post-PACU IV narcotic requirements. Virtually all were discharged on POD 1. Transitioning to outpatient AUS insertion appears reasonable and may have a meaningful impact on patient experience and total costs.
Source of Funding: None
PD37-10 ARTIFICIAL URINARY SPHINCTER REVISION WITH QUICK-CONNECTORSÒ VERSUS SUTURE-TIE CONNECTORS: DOES TECHNIQUE MAKE A DIFFERENCE?
Jack Andrews*, Brian Linder, Joseph Scales, Daniel Elliott, Rochester, MN INTRODUCTION AND OBJECTIVES: While artificial urinary sphincter placement remains the gold standard treatment option for men with stress urinary incontinence, roughly a quarter of men will undergo device revision for recurrent incontinence. For patients undergoing single component device revision the surgical dogma has been to use suture-tie connectors exclusively, as opposed to the Sutureless Quick-ConnectorsÒ (QC), which are routinely used in primary implantations. We sought to evaluate characteristics of artificial urinary sphincter mechanical failures and compare outcomes based on the use of either suture-tied connections or QuickConnectsÒ for single component revisions.
METHODS: A total of 1082 men with stress urinary incontinence underwent primary artificial urinary sphincter procedures from 1983 to 2011 at our institution. Of these, 125 experienced mechanical device malfunction, including 117 that underwent subsequent revision surgery at our institution. With regard to revisions, prior to 1996 all revision cases were performed with suture-tie connections and after this we used QC for revisions. Multiple clinical and surgical variables were evaluated for a potential association with repeat AUS surgery including the type of connector used. RESULTS: Of the 117 patients that underwent revision surgery for primary device malfunction, 46 were single component revisions. In these cases, the tubing connections were performed using suture-tie connectors in 34 (74%) cases and QC in 12 (26%) cases. The median follow-up after revision surgery was 24 months (IQR 7.2, 55.2) ( Table 1 ). There was no significant difference in 5-year device survival between suture-tie and QC (36% vs 61%; p[0.85) (Figure 1 ). There were no cases of device infection or repeat mechanical failure at the connector among revision cases utilizing QC, as compared to five device infections and four repeat mechanical failures among the suture-tie cohort.
